End-of-day quote
Taipei Exchange
23:00:00 03/06/2024 BST
|
5-day change
|
1st Jan Change
|
50.9
TWD
|
-0.97%
|
|
+0.99%
|
-12.69%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
967.9
|
893.5
|
823.6
|
872.5
|
1,315
|
1,563
|
Enterprise Value (EV)
1 |
861.4
|
748.8
|
644
|
730.2
|
1,051
|
1,353
|
P/E ratio
|
12.7
x
|
12.5
x
|
12
x
|
17
x
|
11.8
x
|
14.2
x
|
Yield
|
5.73%
|
4.97%
|
7.55%
|
3.82%
|
3.55%
|
-
|
Capitalization / Revenue
|
1.95
x
|
1.85
x
|
1.8
x
|
2.25
x
|
1.92
x
|
2.48
x
|
EV / Revenue
|
1.74
x
|
1.55
x
|
1.41
x
|
1.89
x
|
1.54
x
|
2.15
x
|
EV / EBITDA
|
7.88
x
|
7.06
x
|
6.71
x
|
10.4
x
|
7.09
x
|
9.32
x
|
EV / FCF
|
421
x
|
9.81
x
|
10.7
x
|
18.1
x
|
8.23
x
|
19.3
x
|
FCF Yield
|
0.24%
|
10.2%
|
9.39%
|
5.53%
|
12.1%
|
5.18%
|
Price to Book
|
2.07
x
|
1.85
x
|
1.62
x
|
1.77
x
|
2.31
x
|
2.48
x
|
Nbr of stocks (in thousands)
|
26,807
|
26,807
|
26,807
|
26,807
|
26,807
|
26,807
|
Reference price
2 |
36.11
|
33.33
|
30.72
|
32.55
|
49.04
|
58.30
|
Announcement Date
|
25/03/19
|
25/03/20
|
15/03/21
|
21/03/22
|
13/03/23
|
13/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
495.6
|
483.3
|
456.7
|
387
|
684.3
|
629.4
|
EBITDA
1 |
109.3
|
106.1
|
95.94
|
70.14
|
148.3
|
145.1
|
EBIT
1 |
91
|
88.31
|
80.93
|
57.24
|
137.4
|
133.4
|
Operating Margin
|
18.36%
|
18.27%
|
17.72%
|
14.79%
|
20.07%
|
21.19%
|
Earnings before Tax (EBT)
1 |
96.27
|
91.33
|
86.94
|
63.48
|
140.8
|
139.1
|
Net income
1 |
76.74
|
72.02
|
69.27
|
51.44
|
112.1
|
111
|
Net margin
|
15.48%
|
14.9%
|
15.17%
|
13.29%
|
16.38%
|
17.64%
|
EPS
2 |
2.841
|
2.667
|
2.567
|
1.913
|
4.156
|
4.120
|
Free Cash Flow
1 |
2.044
|
76.35
|
60.46
|
40.35
|
127.7
|
70.08
|
FCF margin
|
0.41%
|
15.8%
|
13.24%
|
10.43%
|
18.67%
|
11.14%
|
FCF Conversion (EBITDA)
|
1.87%
|
71.98%
|
63.02%
|
57.54%
|
86.1%
|
48.3%
|
FCF Conversion (Net income)
|
2.66%
|
106.02%
|
87.29%
|
78.45%
|
113.95%
|
63.14%
|
Dividend per Share
2 |
2.070
|
1.656
|
2.319
|
1.242
|
1.739
|
-
|
Announcement Date
|
25/03/19
|
25/03/20
|
15/03/21
|
21/03/22
|
13/03/23
|
13/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
107
|
145
|
180
|
142
|
263
|
210
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.04
|
76.4
|
60.5
|
40.4
|
128
|
70.1
|
ROE (net income / shareholders' equity)
|
16.8%
|
15.2%
|
14%
|
10.3%
|
21.1%
|
18.5%
|
ROA (Net income/ Total Assets)
|
9.43%
|
8.93%
|
7.96%
|
5.68%
|
13.2%
|
11%
|
Assets
1 |
813.5
|
806.6
|
870.5
|
906.3
|
851.9
|
1,009
|
Book Value Per Share
2 |
17.40
|
18.00
|
19.00
|
18.40
|
21.30
|
23.50
|
Cash Flow per Share
2 |
6.140
|
5.300
|
3.660
|
3.780
|
4.920
|
4.170
|
Capex
1 |
77.3
|
0.15
|
1.77
|
4.25
|
1.16
|
3.26
|
Capex / Sales
|
15.61%
|
0.03%
|
0.39%
|
1.1%
|
0.17%
|
0.52%
|
Announcement Date
|
25/03/19
|
25/03/20
|
15/03/21
|
21/03/22
|
13/03/23
|
13/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.69% | 50.03M | | +4.94% | 7.88B | | +2.93% | 6.09B | | -5.18% | 3.76B | | -11.51% | 3.54B | | -12.06% | 1.21B | | -28.83% | 1.09B | | +15.98% | 1B | | -8.82% | 931M | | -14.37% | 823M |
Special Foods & Wellbeing Products
|